The University of Chicago Header Logo


Gladell P. Paner to Antineoplastic Agents

This is a "connection" page, showing publications Gladell P. Paner has written about Antineoplastic Agents.
Connection Strength

  1. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
    View in: PubMed
    Score: 0.061
  2. Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances. Urology. 2002 Aug; 60(2):218-22.
    View in: PubMed
    Score: 0.024
  3. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol. 2019 Jan; 37(1):107-114.
    View in: PubMed
    Score: 0.018
  4. Iatrogenic changes in the urinary tract. Histopathology. 2017 Jan; 70(1):10-25.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.